Carbamylated erythropoietin ameliorates cyclosporine nephropathy withoutstimulating erythropoiesis
Carbamylated erythropoietin ameliorates cyclosporine nephropathy withoutstimulating erythropoiesis
批准号:
22591806
负责人:
YAZAWA Koji
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The introduction of cyclosporine (CsA) has improved graft survival, but it causes nephropathy, which limits its clinical utility. To investigate the clinical applications of CEPO, we next evaluated the long-term therapeutic effect of CEPO using a CsA-induced nephropathy model. CsA caused renal dysfunction, while EPO/CEPO administration significantly improved renal function. EPO-treatment significantly increased Hb concentration, while CEPO-treatment neither enhanced nor reduced Hb concentration. These results suggest a new therapeutic approach using CEPO to protect kidneys from CsA-induced nephropathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ラットシクロスポリン腎症モデルにおいてカルバミル化エリスロポエチンは造血作用なく腎保護効果を有する
氨甲酰促红细胞生成素对大鼠环孢素肾病模型具有肾保护作用而无造血作用
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Abe T, Isaka Y, Imamura R, Kakuta Y, Okumi M, Yazawa K, Ichimaru N, Tsuda H, Nonomura N, Takahara S, Okuyama A., Abe T, 阿部 豊文,猪阪 善隆,今村 亮一,斎藤 純,角田 洋一,蔦原 宏一,矢澤 浩治,市丸 直嗣,高原 史郎,奥山 明彦]
通讯作者:
阿部 豊文,猪阪 善隆,今村 亮一,斎藤 純,角田 洋一,蔦原 宏一,矢澤 浩治,市丸 直嗣,高原 史郎,奥山 明彦
DOI:
10.3727/096368911x605501
发表时间:
2012-01-01
期刊:
CELL TRANSPLANTATION
影响因子:
3.3
作者:
[Abe, Toyofumi, Isaka, Yoshitaka, Okuyama, Akihiko]
通讯作者:
Okuyama, Akihiko
海外基金